ENTITY

Anebulo Pharmaceuticals (ANEB US)

2
Analysis
Health CareUnited States
Anebulo Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing disruptive treatments for substance use disorders, such as cannabinoid overdose and the broader addiction landscape. Anebulo Pharmaceuticals serves customers in the United States.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x